Behavioral Interventions for Tobacco Use in HIV-Infected Smokers: A Meta-Analysis
|
|
- Rodney Allison
- 5 years ago
- Views:
Transcription
1 CLINICAL SCIENCE Behavioral Interventions for Tobacco Use in HIV-Infected Smokers: A Meta-Analysis Asheena Keith, MD,* Yuelei Dong, MD,* Jonathan Shuter, MD, and Seth Himelhoch, MD, MPH* Context: Smoking is responsible for increased morbidity and mortality in HIV-infected smokers. Objective: To assess the efficacy of behavioral interventions for smoking cessation among HIV-infected smokers compared with the standard care. Data sources: PubMed, Cochrane, CINHAL, PsychINFO, and Google Scholar were searched for randomized controlled trials published in English. Study selection: Eligibility criteria were randomized controlled trials with targeted behavioral interventions compared with standard of care (or enhanced standard of care) aimed at promoting abstinence in HIV-infected smokers. A total of 17,384 articles were found and 17,371 were excluded; 13 full text articles were obtained and reviewed, and 8 met the eligibility criteria (Κ =0.94). Data extraction: The primary outcome was expired carbon monoxide verified 7-day point prevalence abstinence rates. Adequate sequence generation and freedom from incomplete or selective outcome reporting was used to assess study quality. Results: A total of 1822 subjects from 8 studies yielded a statistically significant effect of behavioral interventions in increasing abstinence in HIV-infected smokers with a moderate effect size (relative risk: 1.51; 95% confidence interval: 1.17 to 1.95). Those studies with interventions of 8 sessions or more had a large effect size for abstinence (relative risk: 2.88; 95% confidence interval: 1.89 to 4.61). When stratified by the number of sessions, there was no heterogeneity. Conclusions: Targeted behavioral smoking cessation interventions are efficacious. Interventions consisting of 8 sessions or more had the greatest treatment efficacy. Received for publication January 14, 2016; accepted March 14, From the *Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD; and Department of Medicine, Division of Infectious Diseases, Montefiore Medical Center and the Albert Einstein College of Medicine, New York, NY. Presented in part at the Institute on Psychiatric Service, October 9, 2015 in New York, NY, and are scheduled to be presented at the American Psychiatric Association, May 16, 2016, Atlanta, GA. The authors have no funding or conflicts of interest to disclose. Correspondence to: Seth Himelhoch, MD, MPH, Department of Psychiatry, University of Maryland School of Medicine, 737 West Lombard Street, Suite 560, Baltimore, MD ( shimelho@psych.umaryland.edu). Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. Key Words: behavioral interventions, HIV smokers, targeted smoking cessation interventions (J Acquir Immune Defic Syndr 2016;72: ) INTRODUCTION Smoking is the leading preventable cause of death and disease in the United States. HIV-infected individuals smoke tobacco at nearly 3 times the rate of the general population. 1 7 These extraordinary smoking rates are associated with greater AIDS-related morbidity, 8,9 greater non-aids related morbidity (including cardiovascular disease, pulmonary disease, and non-aids cancers), 7,10 15 and greater mortality. 16,17 Smoking significantly impacts the progression and outcome of HIV disease, and has been identified as the leading contributor to premature mortality among people with HIV. 18 In fact, a study from Denmark estimated that HIV-positive individuals lose more years from smoking than from HIV infection in and of itself. 19 In our view, shared by others in the field, 4,18,20 24 the single greatest health behavior change that could reduce mortality in this group is smoking cessation. This is well aligned with the personal goals of the target group as surveys have shown that most HIV-infected smokers want to quit. 13,25 27 Thus, establishing the efficacy of interventions for HIV-infected smokers is of critical importance. 28 Although many interventions are effective in helping general population smokers quit, 21 research examining the outcomes of smoking cessation treatments for individuals with HIV is limited. 29,30 Based on the alarming prevalence of smoking and the health-related consequences of smoking among HIV-infected smokers, the 2008 PHS Guideline for Treating Tobacco Use and Dependence specifically called for research that evaluates the efficacy of counseling, and targeted interventions among HIV-infected smokers. 21 To our knowledge, there have been 8 randomized controlled trials evaluating the efficacy of behavioral interventions plus nicotine replacement targeting smoking cessation among people living with HIV/AIDS who smoke. 1,31 37 Some trials demonstrated efficacy 33,38 and several showed no effect. 31,32,34,36,39 The purpose of this meta-analysis was to address the question whether behavioral interventions aimed at smoking cessation led to increased smoking abstinence as measured by expired carbon monoxide (ECO) 7-day point prevalence abstinence () rates compared with control interventions among people living with HIV who smoke. J Acquir Immune Defic Syndr Volume 72, Number 5, August 15,
2 Keith et al J Acquir Immune Defic Syndr Volume 72, Number 5, August 15, 2016 METHODS Eligibility Criteria English language articles from January 1980 through February 2016 were searched. The criteria for inclusion were randomized controlled trials of HIV-infected smokers with or without nicotine replacement therapy with a primary endpoint of carbon monoxide verified 7-day point prevalence. The studies were restricted to smokers of any age with HIV or AIDS with self-reported cigarette use. Studies were excluded if they allowed participants to be enrolled in multiple smoking cessation studies that co-occurred with the study of interest, were not randomized control trials, or used an endpoint of urine nicotine and cotinine. There were no sample size limitations. Information Sources PubMed (1980 to 12/2014), Cochrane (1980 to 12/ 2014), CINHAL ( /2016), PsychINFO ( / 2016), Google Scholar ( /2016), and a literature review through bibliographies of related articles were searched. Search The electronic search strategy was conducted on PubMed,CINHAL,PsychINFO,andCochrane,usingthe following search terms: HIV, AIDS, immune compromised, smokers, behavioral intervention,, nicotine patch, patch treatment, individual therapy, group therapy, motivational interviewing, person counseling, telephone counseling, brief counseling, counseling, behavior. Search filters were used to restrict studies to randomized controlled trials published in English and with human subjects. Google Scholar search included the key phrases such as HIV, randomized controlled trials, and smoking cessation. The bibliographies of included articles were searched for any additional studies. Study Selection Search results were reviewed for any duplicate studies. Two authors (A.K. and Y.D.) independently reviewed all study titles and abstracts for eligibility criteria. If studies met the eligibility criteria through title and abstract, the full article was reviewed. Thirteen full articles were reviewed, and 8 were selected. One study was excluded because the primary endpoint was of urine nicotine and cotinine. Four studies were excluded for not being randomized controlled trials. All the included used ECO-verified 7-day rates for verification of abstinence. Cohen Kappa statistics that assesses the chancecorrected agreement between reviewers was The PRISMA flow diagram (Fig. 1) summarizes the selection process. Data Items The primary endpoint was ECO level verified 7-day. Data Collection Process Two authors (A.K. and Y.D.) independently extracted data from each of the 8 trials. All the data were reviewed for discrepancies. Any disagreement between the 2 reviewers was resolved by consensus. Risk of Bias in Individual Studies All included studies were independently reviewed by 2 reviewers and the validity and reliability were determined according to the Cochrane approach, including adequate sequence generation, allocation concealment, blinding, completeness of outcome data reporting, selective outcome reporting, and presence of other sources of bias. Synthesis of Results We calculated the relative risk (RR) ratios and the weighted pooled RR ratios across studies (Stata 12.0: metan command). We used the DerSimonian and Laird (random effects) model to provide weight estimates for each study (Fig. 2). We chose the random-effects model as it provides a more conservative estimate of weighting than the fixed effect (Mantel Haenszel method) when one is concerned that the fixed-effects assumption, namely that the true effect is the same in each study, may not be met. The Q statistic and I 2 statistic were used to evaluate heterogeneity. The Q statistic quantifies the magnitude of heterogeneity, whereas the I 2 statistic quantifies the total variation due to between-study variance. Publication bias was not formally tested, as tests for publication bias (eg, funnel plot) may be too low to distinguish chance from real asymmetry when using meta-analytic techniques with 10 studies or less. 22,40 RESULTS Study Selection The search of PubMed, Cochrane, CINHAL, PsychINFO, Google Scholar, and a bibliography literature review yielded a total of 17,384 citations after duplicate removal. A total of 17,371 were excluded after review of abstracts indicated eligibility criteria were not met. The remaining 13 full text articles were reviewed for eligibility. Four articles were excluded because they were not randomized controlled trials and 1 for a primary endpoint of urine nicotine and cotinine (Fig. 1). Study Characteristics A total of 8 studies with 1822 subjects were identified for inclusion in the review. All 8 studies were randomized controlled trials in the English language. All studies included nicotine replacement therapy either by prescription, distribution, or referral as a part of the intervention. The study interventions ranged from 4 to 11 sessions, and 5 of the 8 studies had at least 8 sessions. 33,34,36 38 The studies Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved.
3 J Acquir Immune Defic Syndr Volume 72, Number 5, August 15, 2016 Tobacco Use in HIV-Infected Smokers FIGURE 1. Article identification. delivered the behavioral intervention in a range of formats. Three studies used telephone counseling. 36,38,41 Oneusedgroup therapy. 33 Two used computer-based interventions, 31,34 and 3 used individual therapy. 31,32,35 The primary endpoints for all 8 studies were ECO-verified 7-day. All studies compared the intervention group to brief counseling or self-help control conditions (Table 1). Risk of Bias Within Studies All 8 trials were at low risk for bias because of inadequate sequence generation or incomplete data reporting of the primary outcome. There is, however, risk for publication bias. A funnel plot was constructed and by inspection there was no suggestion of publication bias; however, in a meta-analysis with less than 10 studies, funnel plots may not be reliable. 40 Since these were behavioral studies, the nature of the interventions precluded blinding and allocation concealment. Results of Individual Studies Three of the 8 clinical trials reviewed reported treatment efficacy. Wewers et al 37 found statistically significant increase in abstinence at 8 weeks comparing those randomized to the nurse managed, peer led, smoking cessation intervention (n = 8) with the control condition (n = 7) (67.5% vs. 0%). Vidrine et al 38 found a statistically significant increase in abstinence at 3 months among those randomized to the telephone intervention group (n = 48) compared with usual care control (n = 47) (36.8% vs. 10.3%). A larger study conducted by Vidrine et al 36 found a statistically significant increase in abstinence at 3 months for those randomized to the telephone group (n = 236) compared with the control group (n = 238) (11.9% vs. 3.4%). Five of the 8 clinical trials reviewed did not find treatment efficacy Lloyd-Richardson et al 32 found no difference in abstinence at 6 months among those randomized to the motivational enhancement arm (n = 232) compared with those in standard of care (n = 212) (9% vs. 10%). Humfleet et al 31 found no difference in abstinence after 52 weeks among those randomized to individual counseling (n = 69) or computer-based intervention (n = 58) compared with brief counseling control (n = 82) (20.4% vs. 25.6% vs. 19.8%). Shuter et al 34 found no difference in abstinence at 3 months among those randomized to web-based intervention (n = 69) compared with standard-of-care control (n = 69) (10.3% vs. 4.3%). Moadel et al 33 found no difference in abstinence at 3 months among those randomized to group therapy (n = 72) compared with the control condition (n = 73) (19.2 vs. 9.7%). Stanton et al 35 found no evidence that 4 inperson sessions (n = 131) improved cessation rates compared with the standard of care (n = 131) at 3 months (8.5% vs. 9.1%) (Table 1). Synthesis of Results The meta-analysis of the 8 studies evaluating the efficacy of behavioral interventions to increase smoking abstinence among HIV-infected smokers yielded a moderate statistically significant effect size for abstinence Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved
4 Keith et al J Acquir Immune Defic Syndr Volume 72, Number 5, August 15, 2016 FIGURE 2. Forrest plot of efficacy of behavioral interventions for smoking cessation targeting people living with HIV/AIDS who smoke stratified by intervention session number. (RR: 1.51; 95% CI: 1.17 to 1.95). Heterogeneity of the studies was assessed and found to be moderate (I 2 = 43.3%; x 2 = 14.1, d.f. = 8; P = 0.08). When stratified by the number of sessions, those studies with $8 sessions had a large statistically significant effect on abstinence rates (RR: 2.88; 95% CI: 1.89 to 4.61) and no heterogeneity (I 2 =0.0%;x 2 = 1.93; d.f. = 4; P = 0.749). The studies with fewer than 8 sessions or less had nonsignificant results (RR: 1.05; 95% CI:0.77to1.44)andnoheterogeneity(I 2 =0.0%;x 2 = 1.27, d.f. = 3; P = 0.737) (Fig. 2). A sensitivity analysis was conducted to better quantify the effect of the study by Wewer et al on the overall weighted effect of the stratified sample. In the stratified analysis (ie, studies with 8 sessions or more vs. studies with less than 8 sessions), the overall effect including the Wewer s study was RR 2.88 ( ), whereas the overall effect excluding the Wewer s study was an RR 2.70 ( ). DISCUSSION Our systematic review and meta-analysis of the 8 published randomized controlled trials of behavioral tobacco-treatment interventions targeting HIV-infected smokers demonstrated a significant effect in terms of increased abstinence. When stratified by the total number of sessions, studies with 8 or more sessions had a large statistically significant effect size for abstinence, whereas those studies with fewer than 8 sessions yielded nonsignificant results. There was no heterogeneity found with stratification by the total number of sessions. These results suggest that providing a greater number of sessions may be an important determinant of programmatic efficacy. With respect to risk of bias, it is important to note that all the studies in the meta-analysis were deemed to be of high quality. They were all randomized controlled trials with adequate sequence generation and free of selective outcome Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved.
5 J Acquir Immune Defic Syndr Volume 72, Number 5, August 15, 2016 Tobacco Use in HIV-Infected Smokers TABLE 1. Characteristics of Studies for Behavioral Interventions for Smoking Cessation in HIV-Positive Population Investigator Yrs Intervention Demographics Wewers weekly one-on-one 18 yrs or older, 10 cig/d telephone counseling for past year, HIV sessions + offer of vs. self-help Vidrine 38 Vidrine 36 Lloyd- Richardson 32 Moadel 33 Humfleet 31 Shuter 34 Stanton one-on-one telephone counseling sessions + offer of vs. brief counseling + offer of one-on-one telephone counseling sessions + offer of vs. brief counseling + offer of one-one-one motivational interviewing sessions + vs. 2 brief counseling sessions weekly group therapy sessions + offer of vs. brief counseling + offer of one-on-one, in-person counseling sessions vs. 5 web-based sessions vs. brief counseling (all offered ) sessions of web-based treatment programs + offer of vs. brief counseling + offer of in-person sessions of a targeted intervention (Aurora) + vs. 2 in-person sessions of brief advice (enhanced standard care) +, nicotine replacement therapy. 18 yrs or older, HIV, current smoker (.5 cig/d and expired CO.7 ppm), willing to set a quit date within the next 7 days 18 yrs or older, HIV, current smoker (.5 cig/d and expired CO.7 ppm), willing to set a quit date within the next 7 days 18 yrs or older, HIV, current regular smoker (5 cig/d for the past 3 months) Age years $6 on the readiness to quit ladder 18 yrs or older, smoke most days of the month, HIV Self-report smoker, want to quit in next 6 months, HIV 18 yrs or older, current smoker, self-identify as Latino or Hispanic, HIV Total Number Abstinence Rate Intervention Control Endpoint Definition of Abstinence % 0% 8 w 8 ppm ECOverified % 6.4% 3 m 7 ppm ECOverified % 3.4% 3 m 7 ppm ECOverified % 10.0% 2, 4, and 6 m 10 ppm ECOverified % 9.7% 3 m 10 ppm ECOverified 209 IC: 20.4%; CBI: 25.6% 19.7% 52 W 10 ppm ECOverified % 4.3% 3 m 10 ppm ECO verified m: 8% 12 m: 6% 11% 7% 6 and 12 m 10 ppm ECOverified reporting or incomplete outcome reporting in the primary measure The mode of delivery of the behavioral interventions used in these studies differed between trials. Three studies used telephone counseling. 36,38,41 One used group therapy. 33 Two used computer-based interventions, 31,34 and 3 used individual therapy. 31,32,35 Even so, the heterogeneity of the studies was assessed and found to be moderate to low. Although web-based programs have the advantage of flexibility in scheduling, low cost, and the ability to review material as needed, the 2 web-based studies in this metaanalysis had nonsignificant results. Both web-based programs used software that was at the sixth grade reading level. An important difference between the studies was that Shuter et al 34 excluded participants with low literacy scores, whereas Humfleet et al 31 did not. The former study found that a higher educational level was associated with more web pages visited and higher quit rates. This suggests that literacy or perhaps experience using web-based interventions (ie, as a result of the digital divide), which are both associated with higher education, may be important predictors of success with this type of intervention. The advantage of peer-based interventions is that they may bridge potential barriers related to language, culture, and class, and thereby enhance treatment delivery, and they have proved promising in other areas of research. 37,42,43 One of 2 studies that used peer support specialists yielded statistically significant large effect sizes, suggesting that this may be a particularly promising way of delivering targeted behavioral interventions in the future. 33,37 Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved
6 Keith et al J Acquir Immune Defic Syndr Volume 72, Number 5, August 15, 2016 Of note is the finding that the 2 studies that did not assess readiness to quit as a part of their inclusion criteria were also studies that found no treatment effect. 31,32 This may be because of a greater number of participants who were either in precontemplation and/or contemplation and may have negatively contributed to abstinence rates in these trials. The implication of this finding may be that future trials will need to evaluate level of treatment readiness as an eligibility criterion for smoking cessation intervention. Although this meta-analysis was limited to English language articles (ie, Tower of Babel Bias), 44 it still appears that based on these data behavioral interventions targeted at the HIV-infected smokers had a significant effect on increasing smoking abstinence. When stratified by the length of intervention, those studies with interventions of 8 sessions or more had a statistically significant large effect size for abstinence, whereas those studies with interventions consisting of fewer than 8 sessions had nonsignificant results. Future studies may need to include eligibility criteria that emphasize readiness to quit as well and provide $8 intervention sessions. For those studies that are web-based assessment of literacy may be needed. Further study on the utility of peers is an emerging area of research that shows considerable promise. REFERENCES 1. Burkhalter JE, Springer CM, Chhabra R, et al. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7: Kwong J, Bouchard-Miller K. Smoking cessation for persons living with HIV: a review of currently available interventions. J Assoc Nurses AIDS Care. 2010;21: Lifson AR, Lando HA. Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/aids Rep. 2012;9: Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS. 2002; 16: Moscou-Jackson G, Commodore-Mensah Y, Farley J, et al. Smokingcessation interventions in people living with HIV infection: a systematic review. J Assoc Nurses AIDS Care. 2014;25: Niaura R, Shadel WG, Morrow K, et al. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31: Palella FJ Jr, Phair JP. Cardiovascular disease in HIV infection. Curr Opin HIV AIDS. 2011;6: Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women s interagency HIV study. Am J Public Health. 2006;96: Nieman RB, Fleming J, Coker RJ, et al. The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS. 1993;7: Akgun KM, Gordon K, Pisani M, et al. Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr. 2013;62: Calvo-Sanchez M, Perello R, Perez I, et al. Differences between HIVinfected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies. HIV Med. 2013;14: De P, Farley A, Lindson N, et al. Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV. BMC Med. 2013;11: Metersky ML, Colt HG, Olson LK, et al. AIDS-related spontaneous pneumothorax. Risk factors and treatment. Chest. 1995;108: Saves M, Chene G, Ducimetiere P, et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003;37: Winstone TA, Man SF, Hull M, et al. Epidemic of lung cancer in patients with HIV infection. Chest. 2013;143: Lifson AR, Neuhaus J, Arribas JR, et al. Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial. Am J Public Health. 2010;100: Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev. 2009;21: Davies TL, Gompels M, Johnston S, et al. Mind the gap: difference between Framingham heart age and real age increases with age in HIVpositive individuals-a clinical cohort study. BMJ Open. 2013;3:e Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, populationbased cohort study. Clin Infect Dis. 2013;56: Grinspoon SK, Grunfeld C, Kotler DP, et al. State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation. 2008;118: PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. public health service clinical practice Guideline executive summary. Respir Care. 2008;53: Higgins J, Green S. Funnel plots. In: Higgins JPT, Green S, ed. Cochrane Handbook for Systematic Reviews of Interventions Vol Version ed. The Cochrane Collabaration; 2011: Available at: handbook.cochrane.org/chapter_10/10_4_3_1_recommendations_on_ testing_for_funnel_plot_asymmetry.htm. Accessed November 5, Lundgren JD, Battegay M, Behrens G, et al. European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med. 2008;9: Niaura R, Chander G, Hutton H, et al. Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIVinfected individuals. Curr Hiv/aids Rep. 2012;9: Drach L, Holbert T, Maher J, et al. Integrating smoking cessation into HIV care. AIDS Patient Care STDS. 2010;24: Fuster M, Estrada V, Fernandez-Pinilla MC, et al. Smoking cessation in HIV patients: rate of success and associated factors. HIV Med. 2009;10: Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav. 2012;36: Browning KK, Wewers ME, Ferketich AK, et al. Tobacco use and cessation in HIV-infected individuals. Clin Chest Med. 2013;34: Hoffman AC, Starks VL, Gritz ER. The impact of cigarette smoking on HIV/AIDS: urgent need for research and cessation treatment. AIDS Educ Prev. 2009;21: Nahvi S, Cooperman NA. Review: the need for smoking cessation among HIV-positive smokers. AIDS Educ Prev. 2009;21: Humfleet GL, Hall SM, Delucchi KL, et al. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res. 2013;15: Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009;104: Moadel AB, Bernstein SL, Mermelstein RJ, et al. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61: Shuter J, Morales DA, Considine-Dunn SE, et al. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2014;67: Stanton CA, Papandonatos GD, Shuter J, et al. Outcomes of a tailored intervention for cigarette smoking cessation among Latinos living with HIV/AIDS. Nicotine Tob Res. 2015;17: Vidrine DJ, Marks RM, Arduino RC, et al. Efficacy of cell phonedelivered smoking cessation counseling for persons living with HI- V/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14: Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care. 2000;11: Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved.
7 J Acquir Immune Defic Syndr Volume 72, Number 5, August 15, 2016 Tobacco Use in HIV-Infected Smokers 38. Vidrine DJ, Arduino RC, Lazev AB, et al. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006;20: Manuel JK, Lum PJ, Hengl NS, et al. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013;25: Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ. 2007;176: Tesoriero JM, Gieryic SM, Carrascal A, et al. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14: Napoles AM, Ortiz C, Santoyo-Olsson J, et al. Nuevo Amanecer: results of a randomized controlled trial of a community-based, peerdelivered stress management intervention to improve quality of life in Latinas with breast cancer. Am J Public Health. 2015;105(suppl 3): e Srinivas GL, Benson M, Worley S, et al. A clinic-based breastfeeding peer counselor intervention in an urban, low-income population: interaction with breastfeeding attitude. J Hum Lact. 2015;31: Gregoire G, Derderian F, Le LJ. Selecting the language of the publications included in a meta-analysis: is there a tower of Babel bias? J Clin Epidemiol. 1995;48: Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved
Brief Report Efficacy of Cell Phone Delivered Smoking Cessation Counseling for Persons Living With HIV/AIDS: 3-Month Outcomes
Nicotine & Tobacco Research, Volume 14, Number 1 (January 2012) 106 110 Brief Report Efficacy of Cell Phone Delivered Smoking Cessation Counseling for Persons Living With HIV/AIDS: 3-Month Outcomes Damon
More informationSmoking Cessation Interventions in People
The Ontario HIV Rapid Response Service Treatment Network Smoking Cessation Interventions in People with HIV/AIDS Questions What research has been conducted regarding smoking cessation programs/interventions
More informationSmoking Cessation Among Women with and at Risk for HIV: Are They Quitting?
Smoking Cessation Among Women with and at Risk for HIV: Are They Quitting? David Goldberg, MD 1, Kathleen M. Weber, BSN 2, Jennifer Orsi, MPH 3, Nancy A. Hessol, MSPH 4, Gypsyamber D Souza, PhD 5, D. Heather
More informationTitle: SMOKING CESSATION INTERVENTIONS in PERSONS LIVING WITH HIV or. Authors
SMOKING CESSATION PLWH 1 Title: SMOKING CESSATION INTERVENTIONS in PERSONS LIVING WITH HIV or AIDS: A SYSTEMATIC REVIEW Authors Gyasi Moscou-Jackson, RN, BSN, MHS PhD Student Johns Hopkins University School
More informationCurrent Research on Cigarette Smoking Among People with HIV
Curr Addict Rep (2016) 3:19 26 DOI 10.1007/s40429-016-0090-2 TOBACCO (A WEINBERGER, SECTION EDITOR) Current Research on Cigarette Smoking Among People with HIV Nina A. Cooperman 1 Published online: 28
More informationEliScholar A Digital Platform for Scholarly Publishing at Yale
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Public Health Theses School of Public Health January 2015 Evaluating The Effectiveness Of Smoking Cessation Intervention Program
More informationDownloaded from:
Arnup, SJ; Forbes, AB; Kahan, BC; Morgan, KE; McKenzie, JE (2016) The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality. Trials,
More informationPredictors of smoking cessation among Chinese parents of young children followed up for 6 months
Title Predictors of smoking cessation among Chinese parents of young children followed up for 6 months Author(s) Abdullah, ASM; Lam, TH; Loke, AY; Mak, YW Citation Hong Kong Medical Journal, 2006, v. 12
More informationPresenter, Tulsi Jose, MD
POWER TO QUIT: A Randomized Clinical Trial To Encourage Smoking Abstinence Among Person s Experiencing Homelessness Presenter, Tulsi Jose, MD Program in Health Disparities Research Department of Family
More informationWhat Do We Know About Best Practice Prenatal Counseling Interventions In Clinical Settings?
1 What Do We Know About Best Practice Prenatal Counseling Interventions In Clinical Settings? Cathy L. Melvin, PhD, MPH Presented by Catherine L. Rohweder, DrPH The National Conference on Tobacco or Health
More informationPharmacotherapy Safety and Efficacy in Adolescent Smoking Cessation
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2011 Pharmacotherapy Safety and Efficacy in
More informationBackground. Abstinence rates associated with varenicline
What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background
More informationRandomized controlled trial of physical activity counseling as an aid to smoking cessation: 12 month follow-up
Addictive Behaviors 32 (2007) 3060 3064 Short communication Randomized controlled trial of physical activity counseling as an aid to smoking cessation: 12 month follow-up Michael Ussher a,, Robert West
More informationClinical Study Evaluation of a Smoking Cessation Program for HIV Infected Individuals in an Urban HIV Clinic: Challenges and Lessons Learned
AIDS Research and Treatment, Article ID 237834, 8 pages http://dx.doi.org/10.1155/2014/237834 Clinical Study Evaluation of a Smoking Cessation Program for HIV Infected Individuals in an Urban HIV Clinic:
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationSmoking cessation interventions and services
National Institute for Health and Care Excellence Guideline version (Final) Smoking cessation interventions and services [E] Evidence reviews for advice NICE guideline NG92 Evidence reviews FINAL These
More informationSmoking cessation: the value of working together. Dr Donita Baird and Dr Sarah L White
Smoking cessation: the value of working together Dr Donita Baird and Dr Sarah L White Brief Interventions Aim is to start the conversation Generate a quit attempt (momentary desire to quit now) Maximise
More informationThe 5A's are practice guidelines on tobacco use prevention and cessation treatment (4):
Smoking Cessation Module Tobacco use is the single greatest preventable cause of chronic diseases and premature deaths worldwide. The Canadian Cancer Society reports that tobacco product use is responsible
More informationNicotine Replacement Therapy and Brief Motivational Interview for Emergency Department Smokers with Asthma
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 3-4-2008 Nicotine Replacement Therapy and Brief Motivational Interview
More informationconsequences and treatment
Learning Objectives Smoking among persons living with HIV/AIDS: Health consequences and treatment approaches Damon J. Vidrine, Dr.P.H. and Rachel Marks, B.A. Department of Behavioral Science The University
More informationAsthma Pharmacotherapy Adherence Interventions for Adult African-Americans: A Systematic Review. Isaretta L. Riley, MD
Asthma Pharmacotherapy Adherence Interventions for Adult African-Americans: A Systematic Review By Isaretta L. Riley, MD A Master s Paper submitted to the faculty of the University of North Carolina at
More informationSpecialty substance use disorder services following brief alcohol intervention: a meta-analysis of randomized controlled trials
Specialty substance use disorder services following brief alcohol intervention: a meta-analysis of randomized controlled trials May 27, 2016 Joseph E. Glass, PhD, MSW Assistant Professor School of Social
More informationThe impact of asking about interest in free nicotine patches on smoker s stated. intent to change: Real effect or artefact of question ordering?
Impact of asking about interest in free nicotine patches 1 The impact of asking about interest in free nicotine patches on smoker s stated intent to change: Real effect or artefact of question ordering?
More informationBASIC SKILLS FOR WORKING WITH SMOKERS
BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 368 Plantation Street, Worcester, MA 01605 www.umassmed.edu/tobacco 2018 Basic Skills for Working with Smokers 1 Table
More informationFax to Quit: A Model for Delivery of Tobacco Cessation Services to Wisconsin Residents
Fax to Quit: A Model for Delivery of Tobacco Cessation Services to Wisconsin Residents Robin J. Perry, BS, CHES; Paula A. Keller, MPH; Dave Fraser, MS; Michael C. Fiore, MD, MPH ABSTRACT Research has shown
More informationImpact of UNC Health Care s Tobacco-Free Hospital Campus Policy on Hospital Employees
Impact of UNC Health Care s Tobacco-Free Hospital Campus Policy on Hospital Employees February 5, 2008 Prepared for: UNC Health Care Prepared by: UNC School of Medicine Nicotine Dependence Program For
More informationTobacco and Tuberculosis:
Tobacco and Tuberculosis: Risk and Interventions Presented by: Jonathan Golub, PhD, MPH March 3, 2018 1 Presentation Outline Evidence for tobacco as a risk factor for: TB infection, TB disease, TB mortality
More informationSystem change interventions for smoking cessation
System change interventions for smoking cessation Dennis Thomas 1, Michael J Abramson 2, Billie Bonevski 3, Johnson George 2 1 University of New South Wales; 2 Monash University; 3 University of Newcastle
More informationNIH Public Access Author Manuscript Addict Behav. Author manuscript; available in PMC 2014 October 01.
NIH Public Access Author Manuscript Published in final edited form as: Addict Behav. 2013 October ; 38(10): 2541 2546. doi:10.1016/j.addbeh.2013.05.003. A Pilot Study of Screening, Brief Intervention,
More informationArticles. Definitions 46. Board and Staff 48
Articles A publication of The Center for AIDS Information & Advocacy A program of Legacy Community Health Services P.O. Box 66308, Houston, TX 77266-6308 Smoking accounts for more heart attacks in people
More informationSmoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation
Smoking Cessation MariBeth Kuntz, PA-C Duke Center for Smoking Cessation Objectives Tobacco use at population level Tobacco use and control around the world What works for managing tobacco use Common myths
More informationMonth/Year of Review: March 2014 Date of Last Review: April 2012
Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Copyright 2012 Oregon State University. All Rights
More informationWhat is Quitline Iowa?
CONTENTS: What is Quitline Iowa? 0 A telephone counseling helpline for tobacco-use cessation. Free to all residents of the state of Iowa Open Monday-Thursday 7:00am 12:00am / Friday 7:00am 9:00pm / Saturday
More informationTobacco Use among VA Patients Receiving Lung Cancer Screening: Cessation at 1 year Post Screening
Tobacco Use among VA Patients Receiving Lung Cancer Screening: Cessation at 1 year Post Screening Zeliadt SB, Krebs P, Johnson H, Feemster LC, Klein D, Crothers K, Au D, Heffner J Presented by Paul Krebs,
More informationEvaluation of ASC. Asian Smokefree Communities Pilot. Six Month Smoking Cessation Outcomes
Evaluation of ASC Asian Smokefree Communities Pilot Six Month Smoking Cessation Outcomes July 2007 Title: Evaluation of ASC (Asian Smokefree Communities) Pilot: Six-month smoking cessation outcomes, July
More informationURL: <
Citation: Peckham, Emily, Brabyn, Sally, Cook, Liz, Tew, Garry and Gilbody, Simon (2017) Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis. BMC Psychiatry,
More informationBASIC SKILLS FOR WORKING WITH SMOKERS
BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 55 Lave Ave No, Worcester, MA 01655 www.umassmed.edu/tobacco 2016 Basic Skills for Working with Smokers 1 Table of
More informationUsing Significant Others to Motivate Quit Attempts
Using Significant Others to Motivate Quit Attempts Christi Patten, Ph.D. Department of Psychiatry and Psychology Mayo Clinic Rochester, MN Potential Role of Significant Others (SOs) in the Quitting Process
More informationBrief Intervention (BI) for Adolescents
Brief Intervention (BI) for Adolescents Sharon Levy, MD, MPH Director, Adolescent Substance Abuse Program Boston Children s Hospital Associate Professor of Pediatrics Harvard Medical School What is BI?
More informationOXLEAS NHS FOUNDATION TRUST RESEARCH PROPOSAL
OXLEAS NHS FOUNDATION TRUST RESEARCH PROPOSAL Title of the Proposal Does using Motivational Interviewing (MI) in a group setting for people with severe mental illness (SMI) have a positive impact on smoking
More informationThe association between cigarette smoking, virologic suppression, andcd4+lymphocyte count in HIV-Infected Russian women
The association between cigarette smoking, virologic suppression, andcd4+lymphocyte count in HIV-Infected Russian women Jennifer L. Brown, University of Cincinnati Theresa Winhusen, University of Cincinnati
More informationCHRONIC DISEASE PREVALENCE AMONG ADULTS IN OHIO
OHIO MEDICAID ASSESSMENT SURVEY 2012 Taking the pulse of health in Ohio CHRONIC DISEASE PREVALENCE AMONG ADULTS IN OHIO Amy Ferketich, PhD Ling Wang, MPH The Ohio State University College of Public Health
More informationALL QUITLINE FACTS: An Overview of the NAQC 2009 Annual Survey of Quitlines
ALL QUITLINE FACTS: An Overview of the NAQC 2009 Annual Survey of The North American Quitline Consortium (NAQC), established in 2004, provides leadership and forums for health departments, quitline service
More informationPrimary Care Smoking Cessation. GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco
Primary Care Smoking Cessation Dr John McMenamin GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco Target or Tickbox? The Tobacco health target:
More informationYou Can Make a Difference!
You Can Make a Difference! How to help your clients become tobacco free What Does Smoking Cost Us? One study estimates that cost savings of between $1,142 and $1,358 per pregnancy can be achieved for each
More informationCochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library)
A systematic review of smoking cessation and relapse prevention interventions in parents of babies admitted to a neonatal unit (after delivery) Divya Nelson, Sarah Gentry, Caitlin Notley, Henry White,
More informationRobert M. Jacobson, M.D. Department of Pediatric and Adolescent Medicine Mayo Clinic, Rochester, Minnesota
How to Conduct a Systematic Review: A Workshop 24 th Annual Primary Care Research Methods & Statistics Conference, San Antonio, Texas Saturday, December 3, 2011 Robert M. Jacobson, M.D. Department of Pediatric
More informationKaren Nieves-Lugo, PhD George Washington University
Effect of chronic pulmonary lung disease on the decline in physical function in HIV infected and uninfected veterans in the Veterans Aging Cohort Study Karen Nieves-Lugo, PhD George Washington University
More informationAssociation between idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a meta-analysis
Association between idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a meta-analysis David Bédard Méthot, MD, Internal Medicine Resident Evelyne Leblanc, MD, Internal Medicine Resident
More informationParental Opinions of Anti-Tobacco Messages within a Pediatric Dental Office
Parental Opinions of Anti-Tobacco Messages within a Pediatric Dental Office Kari Sims, DDS June 10, 2014 MCH 2014 Research Festival THESIS COMMITTEE Penelope J. Leggott, BDS, MS Melissa A. Schiff, MD,
More informationTobacco Cessation, E- Cigarettes and Hookahs
Objectives Tobacco Cessation, E- Cigarettes and Hookahs Discuss evidence-based tobacco cessation interventions including pharmacologic options. Review e-cigarette and hookah facts and safety considerations.
More informationSmoking Cessation Interventions In Hospital Settings: Implementing the Evidence
Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence Nancy Rigotti, MD Tobacco Research & Treatment Center, General Medicine Division, Massachusetts General Hospital, Harvard
More informationSmoking Counselling and Cessation Service in Hospital Authority 7 May HA Convention 2014
Smoking Counselling and Cessation Service in Hospital Authority 7 May 2014 - HA Convention 2014 On behalf of COC (Family Medicine) Dr Maria Leung Consultant, Department of Family Medicine New Territories
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Effectiveness of collaborative care in patients with combined physical disorders and depression or anxiety disorder: a systematic review
More informationTWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION
Appendix G PHASE OF MANAGEMENT NOTIFICATION ASSESSMENT TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION ACTIONS All patients will be advised on admission that :
More informationHEALTH TARGETS IN PRIMARY CARE
HEALTH TARGETS IN PRIMARY CARE MORE HEART AND DIABETES CHECKS BETTER HELP FOR SMOKERS TO QUIT Better Help for Smokers to Quit 90% of enrolled patients who smoke and are seen by General Practice, will be
More informationThe Nottingham eprints service makes this work by researchers of the University of Nottingham available open access under the following conditions.
Naughton, Felix and Foster, Katharine and Emery, Jo and Cooper, Sue and Sutton, Stephen and Leonardi- Bee, Jo and Jones, Matthew and Ussher, Michael and Whitemore, Rachel and Leighton, Matthew and Montgomery,
More informationREGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY A Pharmacist s Guide
REGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY 2009 A Pharmacist s Guide Aims of the Service The overall aim of the service is to deliver a pharmacy based, one stop specialist smoking
More informationChronic illness and medication adherence in substance users: challenges and opportunities for research fellows FIT 2014 Cape Cod, MA
Chronic illness and medication adherence in substance users: challenges and opportunities for research fellows FIT 2014 Cape Cod, MA Julia H. Arnsten, MD, MPH Professor of Medicine, Epidemiology, and Psychiatry
More informationUMDNJ School of Public Health. Tobacco Dependence Clinic. Annual Report: 2003
UMDNJ School of Public Health Tobacco Dependence Clinic Annual Report: 2003 January 1, 2003 December 31, 2003 2 Tobacco Dependence Clinic at UMDNJ-School of Public Health: Summary Report 2001-2003 Introduction
More informationA systems approach to treating tobacco use and dependence
A systems approach to treating tobacco use and dependence Ann Wendland, MSL Policy Analyst & Cessation Programs Manager NYSDOH Bureau of Tobacco Control ann.wendland@health.ny.gov A systems approach to
More informationBackground and Analysis Objectives Methods and Approach
Cigarettes, Tobacco Dependence, and Smoking Cessation: Project MOM Final Report Lorraine R. Reitzel, Ph.D., The University of Texas, MD Anderson Cancer Center Background and Analysis Objectives Background.
More informationSmoking cessation interventions and services
Smoking cessation interventions and services Systematic reviews Public Health Internal Guideline Development August 2017 National Institute for Health and Care Excellence Disclaimer The recommendations
More informationComparing the Cochrane review of electronic cigarettes to other meta-analyses
Comparing the Cochrane review of electronic cigarettes to other meta-analyses Jamie Hartmann-Boyce Cochrane Tobacco Addiction Group, Nuffield Department of Primary Care Health Sciences, University of Oxford.
More informationTreatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders
University of Kentucky From the SelectedWorks of Chizimuzo T.C. Okoli December, 2010 Treatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders Chizimuzo T.C.
More informationELISSA C. KRANZLER. Annenberg School for Communication University of Pennsylvania
ELISSA C. KRANZLER Annenberg School for Communication elissa.kranzler@asc.upenn.edu EDUCATION Ph.D. Candidate (ABD), Communication Annenberg School for Communication Expected graduation, May 2018 Dissertation:
More informationCotrimoxazole preventive therapy in adults and pregnant women with HIV: a systematic review and meta-analysis
Cotrimoxazole preventive therapy in adults and pregnant women with HIV: a systematic review and meta-analysis Introduction Global efforts to scale-up antiretroviral therapy (ART) averted an estimated 4.2
More informationDeclaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.
Declaration of Conflict of Interest No potential conflict of interest to disclose with regard to the topics of this presentations. Clinical implications of smoking relapse after acute ischemic stroke Furio
More informationTobacco cessation outcomes: The case for milestone-based services
Tobacco cessation outcomes: The case for milestone-based services Disa Cornish 1, Ki Park 2, Mitchell Avery 2 ABSTRACT INTRODUCTION This study focuses on a Midwest State s tobacco quitline. The purpose
More informationThe Science and Practice of Perinatal Tobacco Use Cessation
1 The Science and Practice of Perinatal Tobacco Use Cessation Erin McClain, MA, MPH Catherine Rohweder, DrPH Cathy Melvin, PhD, MPH erin_mcclain@unc.edu Prevention of Tobacco Use and Secondhand Smoke Exposure
More informationCombined pharmacotherapy and behavioural interventions for smoking cessation(review)
Cochrane Database of Systematic Reviews Combined pharmacotherapy and behavioural interventions for smoking cessation(review) Stead LF, Koilpillai P, Fanshawe TR, Lancaster T Stead LF, Koilpillai P, Fanshawe
More information9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives
The Smoking Gun: for Smoking Cessation in Patients with Mental Health Disorders BRENDON HOGAN, PHARMD PGY2 PSYCHIATRIC PHARMACY RESIDENT CTVHCS, TEMPLE, TX 09/23/2016 I would feel comfortable dispensing/prescribing
More informationTOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS
Learning Objectives TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Cheyenne Newsome, PharmD PGY2 Ambulatory Care Resident University of New Mexico College of
More informationJAIDS Journal of Acquired Immune Deficiency Syndromes:Volume 45(5)15 August 2007pp
JAIDS Journal of Acquired Immune Deficiency Syndromes:Volume 45(5)15 August 2007pp 603-605 Conspiracy Beliefs and Trust in Information About HIV/AIDS Among Minority Men Who Have Sex With Men [Letters to
More informationSupplementary Material
Supplementary Material Supplementary Table 1. Symptoms assessed, number of items assessed, scoring, and cut-off points for the psychiatric rating scales: Montgomery Åsberg Depression Rating Scale, Hamilton
More informationElectronic cigarettes for smoking cessation
Electronic cigarettes for smoking cessation Results from the most recent Cochrane update Jamie Hartmann-Boyce*, Hayden McRobbie, Chris Bullen, Rachna Begh, Lindsay F Stead, Peter Hajek *Cochrane Tobacco
More informationManagement of physical health conditions in adults with severe mental disorders
Management of physical health conditions in adults with severe mental disorders WHO GUIDELINES EVIDENCE PROFILES Tobacco cessation Weight management Substance use disorders Cardiovascular disease and cardiovascular
More informationTobacco Use & Multiple Risk Factors:
Overview Tobacco Use & Multiple Risk Factors: Opportunities & for Concurrent Behavior Change Relation between mental health, physical health, and health behaviors Relation between tobacco and other health
More informationAlectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis
Showa Univ J Med Sci 30 2, 309 315, June 2018 Original Alectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis Ryo MANABE 1, Koichi ANDO
More informationVarenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?
Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks? Sonal Singh M.D., M.P.H, Johns Hopkins University Presented by: Sonal Singh, MD MPH September 19, 2012 1 CONFLICTS
More informationP. Waweru Aga Khan University Hospital, R. Anderson University of Pretoria H. Steel University of Pretoria
ecommons@aku Internal Medicine, East Africa Medical College, East Africa January 2013 The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among hiv positive
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews A systematic review of behaviour change interventions targeting physical activity, exercise and HbA1c in adults with type 2 diabetes Leah
More informationSeptember 14, 2018 James O. Prochaska, Ph.D.
More Effective and Inclusive Care by Combining Practices for Individual Patients and Entire Populations September 14, 2018 James O. Prochaska, Ph.D. Director and Professor Cancer Prevention Research Center
More informationA Summary from the 2013World Conference on Lung Cancer Sydney, Australia
A Summary from the 2013World Conference on Lung Cancer Sydney, Australia In 2011, the U.S. National Lung Screening Trial (NLST) has demonstrated that low-dose computed tomography (LDCT) screening of high
More informationProject TEACH Benefits of Quitting Tobacco For People with Mental Health Conditions Rosario Wippold, RN, MPH, TTS
Project TEACH Benefits of Quitting Tobacco For People with Mental Health Conditions Rosario Wippold, RN, MPH, TTS OBJECTIVES 1) Explain the impact of tobacco in patients with mental health conditions 2)
More informationProject ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D.
Project ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D. High Levels Of Tobacco Use Almost twice as likely to smoke as people without disorders (36.1%
More informationSchroeder Institute + Mayo Clinic
Schroeder Institute + Mayo Clinic LEVERAGING TECHNOLOGY FOR SMOKING CESSATION JEFF POTERUCHA, MA, TTS AND MEGAN A. JACOBS, MPH Overview 1. Why technology in the healthcare setting? 2. Web and mobile applications
More informationNote: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.
Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting
More informationCessation Pathways Exploring Opportunities for Developing a Coordinated Smoking Cessation System in Ontario
Generating knowledge for public health E V A L U A T I O N NEWS Cessation Pathways Exploring Opportunities for Developing a Coordinated Smoking Cessation System in Ontario Introduction The process of quitting
More informationWeb enrollment and self assessment for NRT: feasibility and quit rates
Web enrollment and self assessment for NRT: feasibility and quit rates Peter Selby, MBBS Laurie Zawertailo, PhD Sarwar Hussain, MSc Rosa Dragonetti, MSc Tobacco Smoking in Canada Prevalence of Smoking
More informationHealthcare financing systems for increasing the use of tobacco dependence treatment (Review)
Healthcare financing systems for increasing the use of tobacco dependence treatment (Review) Kaper J, Wagena EJ, Severens JL, Van Schayck CP This is a reprint of a Cochrane review, prepared and maintained
More informationPopulation-level Strategies to Prevent and Reduce Tobacco Use Success and Challenge
Population-level Strategies to Prevent and Reduce Tobacco Use Success and Challenge Harlan R. Juster, Ph.D. Director, Bureau of Tobacco Control New York State Department of health November 6, 2013 Learning
More informationCHIROPRACTIC CLINICAL TRIALS SUBMITTED BY THE OFFICE OF THE ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS
REPORT TO CONGRESSIONAL DEFENSE COMMITTEES IN RESPONSE TO SECTION 725(f)(2) OF THE NATIONAL DEFENSE AUTHORIZATION ACT FOR FISCAL YEAR 2010 (PUBLIC LAW 111 84) CHIROPRACTIC CLINICAL TRIALS SUBMITTED BY
More informationOutcomes of an Intensive Smoking Cessation Program for Individuals with Substance Use Disorders
University of Kentucky UKnowledge Nursing Presentations College of Nursing 11-2011 Outcomes of an Intensive Smoking Cessation Program for Individuals with Substance Use Disorders Milan Khara Vancouver
More informationCIGARETTE SMOKING BEHAVIORS AMONG PEOPLE LIVING WITH HIV: ASSOCIATIONS WITH INDIVIDUAL- AND SOCIAL-LEVEL CHARACTERISTICS. by Lauren R.
CIGARETTE SMOKING BEHAVIORS AMONG PEOPLE LIVING WITH HIV: ASSOCIATIONS WITH INDIVIDUAL- AND SOCIAL-LEVEL CHARACTERISTICS by Lauren R. Pacek A dissertation submitted to Johns Hopkins University in conformity
More informationReducing Tobacco Use and Secondhand Smoke Exposure: Quitline Interventions
Reducing Tobacco Use and Secondhand Smoke Exposure: Quitline Interventions Summary Evidence Table Evidence Offering Medication (NRT) through Quitlines and An et al. (2006) Minnesota; smoked five or more
More informationStructural barriers to highly active antiretroviral therapy (HAART) adherence: a systematic review protocol
Structural barriers to highly active antiretroviral therapy (HAART) adherence: a systematic review protocol Garumma Tolu Feyissa MPH 1,5 Aderajew Nigussie MPH 2,5 Tariku Dejene Demissie MSc 3,5 Mirkuzie
More informationTobacco Use Dependence and Approaches to Treatment
University of Kentucky UKnowledge Nursing Presentations College of Nursing 11-2011 Tobacco Use Dependence and Approaches to Treatment Audrey Darville University of Kentucky, audrey.darville@uky.edu Chizimuzo
More informationCochrane Pregnancy and Childbirth Group Methodological Guidelines
Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews
More informationQuit rates among smokers who received pharmacist-provided pharmacotherapy and quitline services versus those who received only quitline services.
Quit rates among smokers who received pharmacist-provided pharmacotherapy and quitline services versus those who received only quitline services. Jill Augustine, PharmD, MPH 1 ; Ryan Seltzer, PhD 2 ; Martin
More information